Drug Type Small molecule drug |
Synonyms AFX 4031 |
Target |
Action modulators |
Mechanism Kallikreins modulators(Kallikreins modulators), TLR modulators(Toll-like receptor modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Rosacea | Phase 2 | United States | 01 Feb 2020 |





